[3] Sinha DK, Balasubramanian A, Tatem AJ, Rivera-Mirabal J, Yu J, Kovac J, Pastuszak AW, Lipshultz LI
Research suggests that DSIP may act on opiate receptors, helping to alleviate somatic symptoms and signs of withdrawal, such as anxiety, with rapid onset and lasting effects
Initial Management and Education Starting Dose: Semaglutide 0.25 mg once weekly (to minimize gastrointestinal side effects), with a plan to titrate to 1.0 mg weekly over several weeks
Supplementary Information accompanies the paper on the Neuropsychopharmacology website ( Supplementary information Rights and permissions About this article Cite this article Lavoie, S., Murray, M., Deppen, P